Synthesis of omega-agatoxin IVA and its related peptides. 1993

H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
Peptide Institute, Inc., Protein Research Foundation, Osaka, Japan.

A potent and selective P type calcium channel blocker isolated from the venom of the funnel web spider Agelenopsis aperta, omega-agatoxin IVA, and its related peptides were synthesized by the solution procedure. Synthetic omega-agatoxin IVA was found to block high-threshold P-type calcium current in rat Purkinje neuron with the same potency as that reported for the natural product. Its disulfide structure was determined by amino acid analysis, gas-phase sequencing and mass spectrometry of the proteolytic fragments. The N-terminus biotinylated and truncated peptides showed the same disulfide-bond-forming profile and the same activities as those of omega-agatoxin IVA, indicating that the N-terminal basic tripeptide, Lys-Lys-Lys, is not important for both the folding and the expression of the biological activity. However, the Trp residue in the molecule might be essential for the toxin to bind tightly with the channel pores.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011689 Purkinje Cells The output neurons of the cerebellar cortex. Purkinje Cell,Purkinje Neuron,Purkyne Cell,Cell, Purkinje,Cell, Purkyne,Cells, Purkinje,Cells, Purkyne,Neuron, Purkinje,Neurons, Purkinje,Purkinje Neurons,Purkyne Cells
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
August 1994, European journal of pharmacology,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
August 1996, Neuroscience letters,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
January 1996, Journal of peptide science : an official publication of the European Peptide Society,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
October 1996, European journal of pharmacology,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
December 1993, FEBS letters,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
March 1995, FEBS letters,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
July 1995, Journal of neuroscience research,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
September 1996, European journal of pharmacology,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
April 2004, Neurochemical research,
H Nishio, and K Y Kumagaye, and S Kubo, and Y N Chen, and A Momiyama, and T Takahashi, and T Kimura, and S Sakakibara
January 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Copied contents to your clipboard!